AAMRNet Calls for New Pilot Fund for Antimicrobials

  06 May 2022

With antimicrobial resistance (AMR) widely acknowledged as one of the biggest threats to global health, a new position statement from the Australian Antimicrobial Resistance Network (AAMRNet) highlights innovative strategies for bringing new antibiotic treatments to market.
Established by MTPConnect in 2020, AAMRNet is an Australian-first network bringing together industry, clinicians and researchers to address the impact of AMR on human health.

AAMRNet and respective member organisations have developed the position statement to guide the way in which pricing and funding of novel antimicrobials in Australia is undertaken.

AAMRNet co-chair and MTPConnect CEO Stuart Dignam says the position statement is aimed at stimulating discussion and spurring action.

Further reading: MTP Connect
Author(s): MTP Connect
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!